5 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Points #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Treatment of Chronic Migraine ... Points #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Group #EBM #Neuro #IM ... #Fremanezumab #Migraine ... #CGRP #CalcitoninGeneRelatedPeptideAntibody ... AdverseEvents #NEJM ... #NEJM
A 27-year-old man with a 2-year history of recurrent, painful skin lesions. A diagnosis of hidradenitis
A diagnosis of hidradenitis ... #Clinical #Derm ... #IM #Hidradenitis ... HidradenitisSuppurativa #NEJM
Legionnaires' Disease
Clinical features:
 • Gl- nausea, vomiting, diarrhea
 • Hyponatremia
 • Elevated transaminases
 • CRP >100
Legionnaires' Disease Clinical ... transaminases • CRP ... Hospital of Baltimore IM ... Legionnaires #Disease #diagnosis